Nathan D. Trinklein, Ph.D.
Affiliations: | Stanford University, Palo Alto, CA |
Google:
"Nathan Trinklein"Mean distance: 16440.9
Parents
Sign in to add mentor| Richard Morris Myers | grad student | 2004 | Stanford | |
| (Transcriptional regulation in the human genome.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Avanzino BC, Prabhakar K, Dalvi P, et al. (2022) A T-cell engaging bispecific antibody with a tumor-selective bivalent folate receptor alpha binding arm for the treatment of ovarian cancer. Oncoimmunology. 11: 2113697 |
| Dang K, Castello G, Clarke SC, et al. (2021) Attenuating CD3 affinity in a PSMAxCD3 bispecific antibody enables killing of prostate tumor cells with reduced cytokine release. Journal For Immunotherapy of Cancer. 9 |
| Malik-Chaudhry HK, Prabhakar K, Ugamraj HS, et al. (2021) TNB-486 induces potent tumor cell cytotoxicity coupled with low cytokine release in preclinical models of B-NHL. Mabs. 13: 1890411 |
| Vafa O, Trinklein ND. (2020) Perspective: Designing T-Cell Engagers With Better Therapeutic Windows. Frontiers in Oncology. 10: 446 |
| Lam N, Trinklein ND, Buelow B, et al. (2020) Author Correction: Anti-BCMA chimeric antigen receptors with fully human heavy-chain-only antigen recognition domains. Nature Communications. 11: 1319 |
| Lam N, Trinklein ND, Buelow B, et al. (2020) Anti-BCMA chimeric antigen receptors with fully human heavy-chain-only antigen recognition domains. Nature Communications. 11: 283 |
| Buelow B, Avanzino B, Balasubramani A, et al. (2020) A CD3 x FRα T-cell engaging bispecific antibody for efficient killing of ovarian cancer cells with minimal cytokine release. Journal of Clinical Oncology. 38: e18050-e18050 |
| Trinklein ND, Pham D, Schellenberger U, et al. (2019) Efficient tumor killing and minimal cytokine release with novel T-cell agonist bispecific antibodies. Mabs |
| Clarke S, Dang K, Li Y, et al. (2019) A novel CD3xPSMA bispecific antibody for efficient T cell mediated killing of prostate tumor cells with minimal cytokine release. Journal of Clinical Oncology. 37: 324-324 |
| Buelow B, Clarke S, Dang K, et al. (2019) Evaluation of monovalent versus biparatopic CD3xPSMA bispecific antibodies for t-cell mediated killing of prostate tumor cells with minimal cytokine release. Journal of Clinical Oncology. 37: e16519-e16519 |